Stepan Company (SCL)

Featured in Small-Cap Stocks

Stepan Company is a common stock listing on the NYSE representing the shares of an operating company in the materials sector. Through its subsidiaries, the company develops and sells specialty and intermediate chemicals used by other manufacturers in a range of end markets in the United States, Europe, Latin America, and other international regions. Its business is organized into three segments: Surfactants, Polymers, and Specialty Products.

The Surfactants segment supplies ingredients used in cleaning, disinfection, personal care, agricultural, and industrial applications. The Polymers segment provides polyurethane polyols, polyester resins, specialty polyols, and phthalic anhydride for uses that include insulation, coatings, adhesives, sealants, elastomers, and construction-related materials. The Specialty Products segment focuses on flavors, emulsifiers, and solubilizers used in food, nutritional supplement, flavoring, and pharmaceutical applications. Founded in 1932 and headquartered in Northbrook, Illinois, Stepan Company operates as a diversified chemical producer with a broad industrial and consumer customer base.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-SCL
$60.09
3.1% Upside
Fair
$75
28.6% Upside
Undervalued
Good
1.58
2.7%
July 29, 2026
-92.9x
1.1x
0.6x
1.311 B
1.894 B
35.2%
94.4%
2.7
-248.3%
-261.7%
Valuation • Fair Value

Stepan Company (NYSE-SCL) Fair Value by Valuation Model

Compare the primary fair value estimate for Stepan Company (NYSE-SCL) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$60.09

Estimated upside of 3.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$63.21

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

$56.75

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$58.08

Comparable-company valuation reference.

Analyst Price Target

$75

Analysts imply upside of 28.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Stepan Company (NYSE-SCL) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Stepan Company (NYSE-SCL)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.343 B

Current operating scale indicator.

Revenue Forecast

2.512 B

Forward revenue estimate.

EBITDA

185.9 M

Current operating profitability reference.

EBITDA Forecast

229.2 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Stepan Company (NYSE-SCL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Stepan Company (NYSE-SCL)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.76

No elevated caution signal from this screen.

Altman Z-Score

2.7

Intermediate risk zone.

FCF / Net Income

-261.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Stepan Company (NYSE-SCL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Stepan Company (NYSE-SCL)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.7%

Income yield reference.

Upcoming Dividend

1.58

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

-248.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Stepan Company (NYSE-SCL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Stepan Company (NYSE-SCL) Stock Forecast & Technical Outlook

Review Stepan Company (NYSE-SCL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Stepan Company (NYSE-SCL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Stepan Company (NYSE-SCL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Stepan Company (NYSE-SCL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Stepan Company (NYSE-SCL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Stepan Company (NYSE-SCL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Stepan Company (NYSE-SCL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Stepan Company (NYSE-SCL) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Stepan Company (NYSE-SCL) Stock FAQ

Quick answers about Stepan Company (NYSE-SCL) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$60.09
Estimated upside 3.1%
Valuation Rating
Undervalued
Estimated upside of 3.1%
Analyst Target
$75
Implied upside 28.6%
Financial Health
Good
Current financial-health read

The current fair value estimate for Stepan Company (NYSE-SCL) is $60.09. This implies an estimated upside of 3.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 3.1% versus the current market price.

The available analyst price target for Stepan Company (NYSE-SCL) is $75. The analyst target implies estimated upside of 28.6%.

The current financial health read for Stepan Company (NYSE-SCL) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Stepan Company (NYSE-SCL) is July 29, 2026.

Based on the current data, dividend yield is 2.7%, upcoming dividend amount is 1.58.

The current P/E ratio listed for Stepan Company (NYSE-SCL) is -92.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Stepan Company is 1.311 B.

The current enterprise value listed for Stepan Company is 1.894 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Stepan Company is NYSE-SCL, and the stock is listed on NYSE.

Stepan Company (NYSE-SCL) is listed on NYSE.

The current debt-to-total-capital ratio listed for Stepan Company is 35.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Stepan Company is 94.4%. Free float helps investors understand how much of the share base is available for public trading.